<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chemotherapy-induced peripheral neurotoxicity is a major problem because it represents the dose-limiting side effect of a significant number of <z:chebi fb="0" ids="35610">antineoplastic drugs</z:chebi>, such as <z:chebi fb="0" ids="27288">vinca alkaloids</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0598589" disease_type="Disease or Syndrome" abbrv="">Hereditary neuropathies</z:e> usually predispose to severe <z:chebi fb="0" ids="28445">vincristine</z:chebi> neurotoxicity </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we report the case of a 56-year-old man with <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e>, also known as spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> type 3, treated with a <z:chebi fb="0" ids="27288">vinca alkaloid</z:chebi> without exacerbation of neurological symptoms </plain></SENT>
</text></document>